Marta Crespo

4.5k total citations · 3 hit papers
52 papers, 2.7k citations indexed

About

Marta Crespo is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Marta Crespo has authored 52 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 26 papers in Pathology and Forensic Medicine and 20 papers in Immunology. Recurrent topics in Marta Crespo's work include Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Marta Crespo is often cited by papers focused on Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (25 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Marta Crespo collaborates with scholars based in Spain, United States and Palestinian Territory. Marta Crespo's co-authors include Francesc Bosch, Emili Montserrat, Beatríz Bellosillo, Neus Villamor, Elı́as Campo, Dolors Colomer, Armando López‐Guillermo, Marı́a Rozman, Sílvia Marcé and Qiong Shen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Marta Crespo

50 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia

2003 970 citations Marta Crespo, Francesc Bosch et al. profile →
The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

2010 600 citations Ulf Klein, Marie Lia et al. Cancer Cell profile →
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

2012 367 citations Marta Crespo, Francesc Bosch et al. profile →

Peers

Marta Crespo

GENET

PFM

IMMUN

ONCOL

Elena Hartmann Germany

José A. García‐Marco Spain

Andreas Bräuninger Germany

Margarita Sánchez‐Beato Spain

Ellen Schlette United States

Evelyne Callet‐Bauchu France

Santiago Montes‐Moreno Spain

Nathalie A. Johnson Canada

Susana Ben‐Neriah Canada

Dirk Kienle Germany

Elena Hartmann Germany

Marta Crespo

1.1k ×0.7

GENET

1.5k ×1.2

PFM

619 ×0.7

IMMUN

675 ×0.8

992 ×1.6

ONCOL

Citations per year, relative to Marta Crespo Marta Crespo (= 1×) peers Elena Hartmann

Countries citing papers authored by Marta Crespo

Since Specialization

Citations

This map shows the geographic impact of Marta Crespo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Crespo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Crespo more than expected).

Fields of papers citing papers by Marta Crespo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Crespo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Crespo. The network helps show where Marta Crespo may publish in the future.

Co-authorship network of co-authors of Marta Crespo

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Crespo. A scholar is included among the top collaborators of Marta Crespo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Crespo. Marta Crespo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Navarro, Vı́ctor, Moraima Jiménez, Marc Bosch, et al.. (2025). Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders. Blood Advances. 9(16). 4180–4189. 1 indexed citations

Jiménez, Moraima, Alba Cabirta, Isabel Ruíz-Camps, et al.. (2023). Impact of COVID‐19 infection on bispecific antibodies treatment in patients diagnosed with B‐cell lymphoproliferative disorders. Hematological Oncology. 41(S2). 607–609. 1 indexed citations

Abrisqueta, Pau, Daniel Medina, Guillermo Villacampa, et al.. (2022). A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression. Blood Advances. 6(21). 5763–5773. 2 indexed citations

Tazón‐Vega, Bárbara, Pau Abrisqueta, Juan C. Nieto, et al.. (2021). Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia. Biomarker Research. 9(1). 37–37. 5 indexed citations

Bosch, Francesc, Blanca Navarro, Marta Crespo, et al.. (2021). Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative. Annals of Hematology. 100(3). 825–830. 2 indexed citations

Bobillo, Sabela, Carlos Palacio, Pau Abrisqueta, et al.. (2020). Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition. Journal of Neuro-Oncology. 149(1). 13–25. 22 indexed citations

Bobillo, Sabela, Marta Crespo, Laura Escudero, et al.. (2020). Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas. Haematologica. 106(2). 513–521. 86 indexed citations

Bobillo, Sabela, Pau Abrisqueta, Bárbara Tazón‐Vega, et al.. (2017). Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells. Blood. 130. 1713–1713. 1 indexed citations

Crespo, Marta, Sabela Bobillo, Pau Abrisqueta, et al.. (2017). Xpo-1 Inhibition Synergizes with BCR Inhibition, Blocks Tumor Growth and Tumor-Associated Macrophages Infiltration and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma. Blood. 130. 2808. 2 indexed citations

10.

Carpio, Cecilia, Pau Abrisqueta, Noelia Purroy, et al.. (2017). Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia. Scientific Reports. 7(1). 12262–12262. 29 indexed citations

11.

Baptista, Maria João, Lluı́s Colomo, Teresa M. Cardesa‐Salzmann, et al.. (2014). Analysis of the IGHV region in Burkitt's lymphomas supports a germinal center origin and a role for superantigens in lymphomagenesis. Leukemia Research. 38(4). 509–515. 12 indexed citations

12.

Purroy, Noelia, Cecilia Carpio, Pau Abrisqueta, et al.. (2013). ZAP-70 Promotes the Infiltration of Malignant B-Lymphocytes into the Bone Marrow by Enhancing Signaling and Migration after CXCR4 Stimulation. PLoS ONE. 8(12). e81221–e81221. 13 indexed citations

13.

Baptista, Maria João, Ana Muntañola, Pau Abrisqueta, et al.. (2012). Differential Gene Expression Profile Associated to Apoptosis Induced by Dexamethasone in CLL Cells According to IGHV/ZAP-70 Status. Clinical Cancer Research. 18(21). 5924–5933. 4 indexed citations

14.

Purroy, Noelia, Pau Abrisqueta, Cecilia Carpio, et al.. (2012). YM155, a Small-Molecule Survivin Suppressant, Mainly Targets Primary CLL Cells Actively Proliferating and Overcomes Microenvironment-Mediated CLL Cell Protection. Blood. 120(21). 3868–3868. 1 indexed citations

15.

Abrisqueta, Pau, Marta Crespo, & Francesc Bosch. (2011). Personalizing treatment for chronic lymphocytic leukemia. Expert Review of Hematology. 4(1). 27–35. 5 indexed citations

16.

Klein, Ulf, Marie Lia, Marta Crespo, et al.. (2010). The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia. Cancer Cell. 17(1). 28–40. 600 indexed citations breakdown →

17.

Codony, Carles, Marta Crespo, Pau Abrisqueta, Emili Montserrat, & Francesc Bosch. (2009). Gene expression profiling in chronic lymphocytic leukaemia. Best Practice & Research Clinical Haematology. 22(2). 211–222. 17 indexed citations

18.

Giné, Eva, Marta Crespo, Maria João Baptista, et al.. (2007). Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Haematologica. 93(1). 75–82. 18 indexed citations

19.

Montés, Juan Francisco Jordán, et al.. (2003). Influence of Talc Dose on Extrapleural Talc Dissemination after Talc Pleurodesis. American Journal of Respiratory and Critical Care Medicine. 168(3). 348–355. 53 indexed citations

20.

Crespo, Marta & Josep M. Campistol. (2003). [Endothelial dysfunction in renal transplantation].. PubMed. 23 Suppl 4. 52–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact